News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,010 Results
Type
Article (40158)
Company Profile (264)
Press Release (661588)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (204669)
Career Advice (2008)
Deals (35503)
Drug Delivery (96)
Drug Development (81392)
Employer Resources (172)
FDA (16237)
Job Trends (14887)
News (346105)
Policy (32598)
Tag
Academia (2561)
Accelerated approval (5)
Adcomms (20)
Allergies (87)
Alliances (49603)
ALS (95)
Alzheimer's disease (1385)
Antibody-drug conjugate (ADC) (134)
Approvals (16230)
Artificial intelligence (266)
Autoimmune disease (28)
Automation (17)
Bankruptcy (360)
Best Places to Work (11655)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (191)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (292)
Cancer (2326)
Cardiovascular disease (179)
Career advice (1677)
Career pathing (30)
CAR-T (161)
Cell therapy (449)
Cervical cancer (20)
Clinical research (66354)
Collaboration (863)
Company closure (2)
Compensation (569)
Complete response letters (20)
COVID-19 (2598)
CRISPR (42)
C-suite (251)
Cystic fibrosis (102)
Data (2346)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (276)
Diagnostics (6393)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (87189)
Editorial (39)
Employer branding (21)
Employer resources (146)
Events (113059)
Executive appointments (746)
FDA (17619)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (780)
Gene editing (111)
Generative AI (20)
Gene therapy (316)
GLP-1 (720)
Government (4444)
Grass and pollen (4)
Guidances (162)
Healthcare (18883)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (135)
Indications (29)
Infectious disease (2743)
Inflammatory bowel disease (146)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (98)
Interviews (312)
IPO (16566)
IRA (40)
Job creations (3639)
Job search strategy (1422)
Kidney cancer (10)
Labor market (43)
Layoffs (477)
Leadership (17)
Legal (7915)
Liver cancer (76)
Lung cancer (325)
Lymphoma (158)
Machine learning (9)
Management (58)
Manufacturing (330)
MASH (79)
Medical device (13386)
Medtech (13391)
Mergers & acquisitions (19512)
Metabolic disorders (711)
Multiple sclerosis (85)
NASH (17)
Neurodegenerative disease (95)
Neuropsychiatric disorders (28)
Neuroscience (1947)
NextGen: Class of 2025 (6542)
Non-profit (4486)
Now hiring (40)
Obesity (371)
Opinion (209)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (154)
Partnered (22)
Patents (245)
Patient recruitment (117)
Peanut (47)
People (57497)
Pharmaceutical (65)
Pharmacy benefit managers (20)
Phase I (20677)
Phase II (29261)
Phase III (21731)
Pipeline (1390)
Policy (147)
Postmarket research (2568)
Preclinical (8810)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (388)
Real estate (5918)
Recruiting (65)
Regulatory (22379)
Reports (48)
Research institute (2345)
Resumes & cover letters (349)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (134)
Series B (93)
Service/supplier (11)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3609)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (51)
The Weekly (32)
Vaccines (700)
Venture capitalists (42)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Today (116)
Last 7 days (963)
Last 30 days (3229)
Last 365 days (32617)
2025 (11996)
2024 (35365)
2023 (40177)
2022 (51318)
2021 (55887)
2020 (54236)
2019 (46656)
2018 (35102)
2017 (32199)
2016 (31596)
2015 (37655)
2014 (31392)
2013 (26431)
2012 (28648)
2011 (29348)
2010 (27413)
Location
Africa (718)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38099)
Australia (6238)
California (6446)
Canada (2068)
China (546)
Colorado (274)
Connecticut (281)
Delaware (158)
Europe (82186)
Florida (957)
Georgia (216)
Idaho (57)
Illinois (550)
India (25)
Indiana (323)
Iowa (11)
Japan (173)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (926)
Massachusetts (4797)
Michigan (226)
Minnesota (406)
Mississippi (2)
Missouri (82)
Montana (30)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1800)
New Mexico (28)
New York (1811)
North Carolina (995)
North Dakota (8)
Northern California (2841)
Ohio (210)
Oklahoma (14)
Oregon (37)
Pennsylvania (1435)
Puerto Rico (13)
Rhode Island (33)
South America (1102)
South Carolina (26)
South Dakota (1)
Southern California (2416)
Tennessee (106)
Texas (952)
United States (24144)
Utah (188)
Virginia (153)
Washington D.C. (64)
Washington State (574)
West Virginia (3)
Wisconsin (56)
702,010 Results for "autoimmune inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cell therapy
5 CAR T Cell Therapies With Autoimmune Readouts in 2025
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune disorders, with several early- to mid-stage readouts expected this year.
March 17, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
May 12, 2025
·
4 min read
Press Releases
Innovo Therapeutics Announces Positive Phase 1 Results for INV-101, a Novel Immuno-Metabolic Modulator for Autoimmune Diseases
May 12, 2025
·
2 min read
Funding
Merida Enters Autoimmune and Allergy Arena With $121M Series A
Merida is working on a selective therapy for Graves’ disease, leveraging targeted therapies that can deplete disease-causing autoantibodies.
April 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
April 14, 2025
·
8 min read
Job trends
Cell Therapy Biotechs Hunt for Autoimmune Expertise in Pivot From Oncology
In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right expertise is in place to tackle the new disease area.
November 6, 2024
·
6 min read
·
Annalee Armstrong
Press Releases
Merida Biosciences Launches with $121M to Create Therapeutics for Multiple Autoimmune and Allergic Diseases
April 8, 2025
·
4 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases
April 2, 2025
·
7 min read
Press Releases
ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model
May 5, 2025
·
10 min read
1 of 70,201
Next
